Patent intelligence · US
US 9265804
Compositions and methods for treatment of cancer using bacteria
Compositions and methods for treatment of cancer using bacteria
Patent details — US 9265804
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 23, 2016
- Expiration
- Feb 18, 2036
- Applicant
- Decoy Biosystems, Inc.
- Claims
- 14
- CPC classes
- A61K, A61K2039/521, A61K2039/522, A61K2039/523
Quick answer
US 9265804 (Compositions and methods for treatment of cancer using bacteria) is held by Decoy Biosystems, Inc.. Status: granted. Granted Feb 23, 2016. Expires Feb 18, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Decoy Biosystems, Inc.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K2039/521, A61K2039/522, A61K2039/523, A61K2039/585, A61K31/11
More from Decoy Biosystems, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12226474
Methods and compositions for treating infections
granted -
US 11147844
Methods of treatment of infections using bacteria
granted -
US 11045504
Compositions and methods for treatment of cancer using bacteria
granted -
US 10195259
Compositions and methods for treatment of cancer using bacteria
granted -
US 10052371
Compositions and methods for treatment of cancer using bacteria
granted
Frequently asked questions
What is US patent 9265804?
US 9265804 (Compositions and methods for treatment of cancer using bacteria) is held by Decoy Biosystems, Inc.. Status: granted. Granted Feb 23, 2016. Expires Feb 18, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9265804?
Decoy Biosystems, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 6 pharmaceutical patents for this assignee.
When does US 9265804 expire?
Our index shows an expiration date of Feb 18, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.